查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1766095

白色生物技术全球市场：未来预测（至 2032 年）—按产品类型、原料、组织类型、技术、最终用户和地区进行分析

White Biotechnology Market Forecasts to 2032 - Global Analysis By Product (Biofuels, Biomaterials, Biochemicals and Industrial Enzymes), Source Material, Organism Types, Technologies, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球白色生物技术市场预计在 2025 年达到 3,824 亿美元，到 2032 年将达到 8,224 亿美元，预测期内的复合年增长率为 11.56%。

白色生物技术（有时也称为工业生物技术）是指利用活细胞和酵素来生产永续产品和工业流程。它致力于在化学品、矿物和燃料的生产过程中，以生物基製程取代传统的石油基製程。透过利用生物质等可再生资源，白色生物技术可以提高製程效率、降低能耗并减少环境影响。它对生质能源、纺织、农业和製药等行业至关重要。这种环保策略鼓励在生产过程中减少废弃物、生物分解性并减少二氧化碳排放，所有这些都有助于循环经济。

根据国际能源总署（IEA）的数据，现代生质能源目前占全球所有可再生能源的50%，预计到2025年将以每年3%的速度成长。

对永续和环保生产的需求不断增加

白色生物技术作为一种遵守严格环境法规和减少碳排放的方式，在工业领域越来越受欢迎。它能够生产生物分解性的材料，从而减少长期的生态危害。消费者对绿色产品的偏好推动了生物製品市场的蓬勃发展。各国政府和组织正在资助生物技术研究、基础设施建设和生态创新。因此，白色生物技术正逐渐成为永续工业转型的关键要素。

研发成本高且监管障碍

开发创新生物技术製程需要专业人员、先进的设备和大量的测试环节。监管壁垒要求严格遵守安全和环境法规，这使得市场准入更加困难。取得监管部门的批准成本高且耗时。这些障碍限制了中小企业的进入，并延缓了产品的商业化。这可能会抑制创新，并限制整体市场扩张。

合成生物学和酵素工程的进展

合成生物学和酵素工程的进步使得开发能够更永续地生产生物基产品、燃料和化学品的专用微生物成为可能。改进的酵素工程可以提高反应的选择性和产量，从而降低成本并减少负面环境影响。此外，合成生物学加速了菌株优化和代谢途径设计，使商业性生物製程更具扩充性。这些技术符合全球永续性目标，促进了从石化到可再生资源的转变。越来越多的企业采用白色生物技术，因为它能够提供更具成本效益和环保的製造流程。

与传统化学製程的竞争

数十年的优化使传统技术在大规模生产中更具成本效益。由于基础设施完善，它们不需要更多资金。生技产品监管核准的不确定性是许多产业不愿转型的另一个原因。化学製程由于生产速度更快而具有竞争优势。这使得白色生物技术难以获得市场占有率和更广泛的认可。

COVID-19的影响

新冠疫情对白色生物技术市场产生了多方面的影响。虽然供应链中断和劳动力短缺最初阻碍了生产和研发活动，但它也导致对永续的本地生物基产品的需求激增。人们对健康、卫生和永续性的日益关注加速了白色生物技术在製药、食品和清洁产品领域的应用。各国政府和各行业加大了对生物基创新的投资，以确保其韧性，最终推动了长期成长，并促进了绿色生物加工技术的进步。

生医材料预计将在预测期内实现最大幅度增长

生医材料领域预计将在预测期内占据最大的市场占有率，这得益于其提供石油基材料的永续替代品。该领域正在推动生物分解性塑胶、医疗植入和包装解决方案的创新，以符合全球环境法规。发酵和酶促製程的进步使生医材料生产更加高效且扩充性。医疗保健、农业和消费品等行业日益增长的需求将推动市场扩张。随着企业优先考虑环保和可再生解决方案，生医材料将继续推动白色生物技术应用的成长。

预计工业和製造业在预测期内将实现最高的复合年增长率。

由于生物基製程提高了生产效率，预计工业製造领域将在预测期内实现最高成长率。利用可再生原料可以减少对石化燃料的依赖，从而实现永续的製造方法。透过白色生物技术开发的酵素和微生物可以简化化学反应，从而减少能源消耗和废弃物产生。该产业还支持生物分解性塑胶和环保化学品的开发，以符合全球环境目标。对绿色工业解决方案日益增长的需求将继续推动该领域的创新和投资。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场占有率，这得益于不断增长的工业需求、政府对永续生产的激励措施以及大规模的生物基原料供应。中国、印度和日本等国家正大力投资研发和生物精製基础设施。日益增长的环境问题以及减少对石化产品依赖的需求正推动市场发展。快速的都市化和强劲的工业生产进一步刺激了需求，尤其是在製药、食品和生质塑胶领域，这使得亚太地区成为未来白色生物技术扩张的关键枢纽。

复合年增长率最高的地区：

在预测期内，北美预计将呈现最高的复合年增长率，这得益于美国和加拿大的强劲贡献。该地区在先进生物加工技术、专利申请和生物技术新兴企业处于领先地位。对永续生物製造（尤其是生质燃料、特殊酵素和工业化学品）的监管支持和资金支持正在推动市场发展。然而，高昂的生产成本和严格的合规要求可能会阻碍快速扩展。成长仍在继续，但更加稳定且研究密集，这使得北美成为白色生物技术创新而非产量扩张的领导者。

免费客製化服务

本报告的所有订阅者均可享有以下免费自订选项之一：

  • 公司简介
    • 对其他公司（最多 3 家）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 简介

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 主要研究资料
    • 二手研究资讯来源
    • 先决条件

第三章市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 市场机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 企业之间的竞争

5. 全球白色生物技术市场（按产品）

  • 生质燃料
  • 生物材料
  • 生医材料
  • 工业酵素

6. 全球白色生物技术市场（依原料）

  • 农业原料
  • 森林生物质
  • 工业废弃物
  • 海洋生物质
  • 其他成分

7. 全球白色生物技术市场（依组织类型）

  • 细菌
  • 酵母菌
  • 真菌
  • 微藻类
  • 其他类型的组织

8. 全球白色生物技术市场（按技术）

  • 生物催化
  • 生物加工
  • 生物合成
  • 其他技术

第九章全球白色生物技术市场（按最终用户）

  • 农业
  • 食品/饮料
  • 工业/製造业
  • 个人护理
  • 其他最终用户

第 10 章全球白色生物技术市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併与收购（M&A）
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Koninklijke DSM NV
  • DuPont de Nemours, Inc.
  • BASF SE
  • Evonik Industries AG
  • Novozymes A/S
  • Corbion NV
  • Lonza Group Ltd
  • Amyris, Inc.
  • Ginkgo Bioworks
  • Kaneka Corporation
  • Akzo Nobel NV
  • Henkel AG & Co. KGaA
  • Mitsubishi Corporation
  • Cargill, Inc.
  • Archer Daniels Midland Company（ADM）
  • Fujifilm Holdings Corporation
  • BioAmber
  • Codexis, Inc.
Product Code: SMRC29951

According to Stratistics MRC, the Global White Biotechnology Market is accounted for $382.40 billion in 2025 and is expected to reach $822.40 billion by 2032 growing at a CAGR of 11.56% during the forecast period. White biotechnology, sometimes referred to as industrial biotechnology, is the process of creating sustainable products and industrial processes using live cells and enzymes. It emphasises the replacement of traditional petroleum-based procedures with bio-based processes for the production of chemicals, minerals, and fuels. White biotechnology improves process efficiency, lowers energy consumption, and lessens its impact on the environment by utilising renewable resources like biomass. It is essential to industries including bioenergy, textiles, agriculture, and pharmaceuticals. This environmentally beneficial strategy encourages waste reduction, biodegradability, and a smaller carbon footprint during manufacturing, all of which contribute to the circular economy.

According to the International Energy Agency (IEA), Modern bioenergy constitutes 50% of all renewable energy used in the world today and is expected to grow 3% per year through 2025.

Market Dynamics:

Driver:

Rising demand for sustainable and eco-friendly production

White biotechnology is becoming more and more popular among industries as a way to meet strict environmental laws and lower carbon footprints. It reduces long-term ecological harm by making it possible to produce biodegradable materials. The market for bio-manufactured items is being driven by consumers' preference for green products. Governments and organisations are sponsoring biotech research and infrastructure, as well as eco-innovations. White biotechnology is therefore emerging as a key component of sustainable industrial change.

Restraint:

High R&D costs and regulatory hurdles

Innovative biotechnological process development calls for specialised staff, sophisticated machinery, and extensive testing stages. By requiring stringent adherence to safety and environmental regulations, regulatory barriers make market entry even more difficult. Getting agency clearances can be expensive and time-consuming. These obstacles restrict the involvement of small and medium-sized businesses and postpone the commercialisation of products. Innovation may consequently stall, which would limit market expansion as a whole.

Opportunity:

Advancements in synthetic biology and enzyme engineering

Advancements in synthetic biology and enzyme engineering enable the development of specialised microbes capable of more sustainably producing bio-based products, fuels, and chemicals. Improved enzyme engineering lowers expenses and has a less negative effect on the environment by increasing reaction selectivity and yield. Additionally, strain optimisation and metabolic pathway design are accelerated by synthetic biology, increasing the scalability of commercial bioprocesses. In line with the objectives of global sustainability, these technologies facilitate the transition from petrochemical to renewable resources. Because white biotechnology offers more cost-effective and environmentally friendly manufacturing processes, companies are adopting it more and more.

Threat:

Competition from conventional chemical processes

Decades of optimisation have made these conventional techniques more cost-effective for large-scale manufacturing. Their extensive infrastructure eliminates the need for more funding. The uncertainty surrounding regulatory approvals for biotechnology products is another reason why many industries are reluctant to make the shift. Chemical processes' quicker output rates give them a competitive advantage as well. White biotechnology hence has difficulties expanding its market share and garnering broader acceptance.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the White Biotechnology Market. While supply chain disruptions and workforce shortages initially hindered production and research activities, the demand for sustainable and locally produced bio-based products surged. Increased focus on health, hygiene, and sustainability accelerated the adoption of white biotechnology in pharmaceuticals, food, and cleaning products. Governments and industries invested more in bio-based innovations to ensure resilience, ultimately fostering long-term growth and driving advancements in green bioprocessing technologies.

The biomaterials segment is expected to be the largest during the forecast period

The biomaterials segment is expected to account for the largest market share during the forecast period by offering sustainable alternatives to petroleum-based materials. It drives innovation in biodegradable plastics, medical implants, and packaging solutions, aligning with global environmental regulations. Advancements in fermentation and enzymatic processes enhance the efficiency and scalability of biomaterial production. Increasing demand from industries such as healthcare, agriculture, and consumer goods boosts market expansion. As companies prioritize eco-friendly and renewable solutions, biomaterials continue to fuel growth in white biotechnology applications.

The industrial manufacturing segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the industrial manufacturing segment is predicted to witness the highest growth rate, due to enhanced production efficiency through bio-based processes. It reduces reliance on fossil fuels by utilizing renewable raw materials, leading to sustainable manufacturing practices. Enzymes and microbes developed through white biotechnology streamline chemical reactions, cutting down energy consumption and waste generation. This segment also supports the development of biodegradable plastics and eco-friendly chemicals, aligning with global environmental goals. Increasing demand for green industrial solutions continues to drive innovations and investments in this sector.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to increasing industrial demand, government incentives for sustainable production, and a large bio-based feedstock supply. Countries like China, India, and Japan are investing heavily in R&D and bio-refinery infrastructure. The market benefits from rising environmental concerns and the need to reduce reliance on petrochemicals. Rapid urbanization and strong industrial output further fuel demand, particularly in pharmaceuticals, food, and bio-plastics, positioning Asia Pacific as a key hub for future white biotech expansion.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong contributions from the United States and Canada. The region leads in advanced bioprocess technologies, patent filings, and biotech startups. Regulatory support and funding for sustainable biomanufacturing, especially in biofuels, specialty enzymes, and industrial chemicals, propel market development. However, high production costs and strict compliance requirements may hinder rapid scalability. While growth continues, it is more stable and research-intensive, making North America a leader in white biotechnology innovation rather than volume-driven expansion.

Key players in the market

Some of the key players profiled in the White Biotechnology Market include Koninklijke DSM N.V., DuPont de Nemours, Inc., BASF SE, Evonik Industries AG, Novozymes A/S, Corbion N.V., Lonza Group Ltd, Amyris, Inc., Ginkgo Bioworks, Kaneka Corporation, Akzo Nobel N.V., Henkel AG & Co. KGaA, Mitsubishi Corporation, Cargill, Inc., Archer Daniels Midland Company (ADM), Fujifilm Holdings Corporation, BioAmber and Codexis, Inc.

Key Developments:

In April 2025, DSM partnered with Inscripta to co-develop innovative well-aging skincare ingredients. Leveraging Inscripta's GenoScaler(TM) platform, the collaboration aims to engineer microbial strains for sustainable production of bio-based cosmetic actives. This partnership enhances dsm firmenich's biotech capabilities in personal care through precision strain development and green manufacturing.

In September 2024, DuPont and Royal DSM established a 50/50 joint venture named Actamax Surgical Materials LLC to develop and commercialize innovative biodegradable hydrogel-based biomedical materials. These include surgical sealants, tissue adhesives, and adhesion barriers aimed at enhancing patient outcomes, minimizing surgical complications, and supporting advanced wound management solutions.

In June 2024, BASF and Saarland, Marburg & Kaiserslautern Universities launched a joint research project using Basfia succiniciproducens to convert sugar and CO2 into bio-based fumaric acid-an important intermediate in the chemical industry.

Products Covered:

  • Biofuels
  • Biomaterials
  • Biochemicals
  • Industrial Enzymes
  • Other Products

Source Materials Covered:

  • Agricultural Feedstock
  • Forest Biomass
  • Industrial Waste
  • Marine Biomass
  • Other Source Materials

Organism Types Covered:

  • Bacteria
  • Yeast
  • Fungi
  • Microalgae
  • Other Organism Types

Technologies Covered:

  • Biocatalysis
  • Bioprocessing
  • Biosynthesis
  • Other Technologies

End Users Covered:

  • Agriculture
  • Food & Beverage
  • Industrial Manufacturing
  • Personal Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global White Biotechnology Market, By Product

  • 5.1 Introduction
  • 5.2 Biofuels
  • 5.3 Biomaterials
  • 5.4 Biochemicals
  • 5.5 Industrial Enzymes

6 Global White Biotechnology Market, By Source Material

  • 6.1 Introduction
  • 6.2 Agricultural Feedstock
  • 6.3 Forest Biomass
  • 6.4 Industrial Waste
  • 6.5 Marine Biomass
  • 6.6 Other Source Materials

7 Global White Biotechnology Market, By Organism Types

  • 7.1 Introduction
  • 7.2 Bacteria
  • 7.3 Yeast
  • 7.4 Fungi
  • 7.5 Microalgae
  • 7.6 Other Organism Types

8 Global White Biotechnology Market, By Technologies

  • 8.1 Introduction
  • 8.2 Biocatalysis
  • 8.3 Bioprocessing
  • 8.4 Biosynthesis
  • 8.5 Other Technologies

9 Global White Biotechnology Market, By End User

  • 9.1 Introduction
  • 9.2 Agriculture
  • 9.3 Food & Beverage
  • 9.4 Industrial Manufacturing
  • 9.5 Personal Care
  • 9.6 Other End Users

10 Global White Biotechnology Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Koninklijke DSM N.V.
  • 12.2 DuPont de Nemours, Inc.
  • 12.3 BASF SE
  • 12.4 Evonik Industries AG
  • 12.5 Novozymes A/S
  • 12.6 Corbion N.V.
  • 12.7 Lonza Group Ltd
  • 12.8 Amyris, Inc.
  • 12.9 Ginkgo Bioworks
  • 12.10 Kaneka Corporation
  • 12.11 Akzo Nobel N.V.
  • 12.12 Henkel AG & Co. KGaA
  • 12.13 Mitsubishi Corporation
  • 12.14 Cargill, Inc.
  • 12.15 Archer Daniels Midland Company (ADM)
  • 12.16 Fujifilm Holdings Corporation
  • 12.17 BioAmber
  • 12.18 Codexis, Inc.

List of Tables

  • Table 1 Global White Biotechnology Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global White Biotechnology Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global White Biotechnology Market Outlook, By Biofuels (2024-2032) ($MN)
  • Table 4 Global White Biotechnology Market Outlook, By Biomaterials (2024-2032) ($MN)
  • Table 5 Global White Biotechnology Market Outlook, By Biochemicals (2024-2032) ($MN)
  • Table 6 Global White Biotechnology Market Outlook, By Industrial Enzymes (2024-2032) ($MN)
  • Table 7 Global White Biotechnology Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 8 Global White Biotechnology Market Outlook, By Source Material (2024-2032) ($MN)
  • Table 9 Global White Biotechnology Market Outlook, By Agricultural Feedstock (2024-2032) ($MN)
  • Table 10 Global White Biotechnology Market Outlook, By Forest Biomass (2024-2032) ($MN)
  • Table 11 Global White Biotechnology Market Outlook, By Industrial Waste (2024-2032) ($MN)
  • Table 12 Global White Biotechnology Market Outlook, By Marine Biomass (2024-2032) ($MN)
  • Table 13 Global White Biotechnology Market Outlook, By Other Source Materials (2024-2032) ($MN)
  • Table 14 Global White Biotechnology Market Outlook, By Organism Type (2024-2032) ($MN)
  • Table 15 Global White Biotechnology Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 16 Global White Biotechnology Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 17 Global White Biotechnology Market Outlook, By Fungi (2024-2032) ($MN)
  • Table 18 Global White Biotechnology Market Outlook, By Microalgae (2024-2032) ($MN)
  • Table 19 Global White Biotechnology Market Outlook, By Other Organism Types (2024-2032) ($MN)
  • Table 20 Global White Biotechnology Market Outlook, By Technology (2024-2032) ($MN)
  • Table 21 Global White Biotechnology Market Outlook, By Biocatalysis (2024-2032) ($MN)
  • Table 22 Global White Biotechnology Market Outlook, By Bioprocessing (2024-2032) ($MN)
  • Table 23 Global White Biotechnology Market Outlook, By Biosynthesis (2024-2032) ($MN)
  • Table 24 Global White Biotechnology Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 25 Global White Biotechnology Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global White Biotechnology Market Outlook, By Agriculture (2024-2032) ($MN)
  • Table 27 Global White Biotechnology Market Outlook, By Food & Beverage (2024-2032) ($MN)
  • Table 28 Global White Biotechnology Market Outlook, By Industrial Manufacturing (2024-2032) ($MN)
  • Table 29 Global White Biotechnology Market Outlook, By Personal Care (2024-2032) ($MN)
  • Table 30 Global White Biotechnology Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.